[go: up one dir, main page]

ES2160951T3 - Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos. - Google Patents

Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos.

Info

Publication number
ES2160951T3
ES2160951T3 ES97920753T ES97920753T ES2160951T3 ES 2160951 T3 ES2160951 T3 ES 2160951T3 ES 97920753 T ES97920753 T ES 97920753T ES 97920753 T ES97920753 T ES 97920753T ES 2160951 T3 ES2160951 T3 ES 2160951T3
Authority
ES
Spain
Prior art keywords
antivirical
agents
same
distamycin
antitumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97920753T
Other languages
English (en)
Inventor
Paolo Cozzi
Italo Beria
Marina Caldarelli
Maria Cristina Geroni
Enrico Pesenti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Italia SRL
Original Assignee
Pharmacia and Upjohn SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia and Upjohn SpA filed Critical Pharmacia and Upjohn SpA
Application granted granted Critical
Publication of ES2160951T3 publication Critical patent/ES2160951T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrrole Compounds (AREA)

Abstract

UN COMPUESTO QUE ES UN DERIVADO DE DISTAMICINA DE FORMULA (I) EN LA QUE N ES 2, 3 O 4; R 0 ES ALQUILO C 1 - C SUB,4 O HALOALQUILO C 1 - C 3 ; R 1 Y R 2 , QUE PUEDEN SER IGUALES O DIFERENTES, SON CADA UNO HIDROGENO, ALQUILO C 1 - C 4 OPCIONALMENTE SUSTITUIDO POR UNO O MAS ATOMOS DE FLUOR, O ALCOXI C 1 - C 4 ; X ES UN ATOMO DE HALOGENO; B SE SELECCIONA DE (A, B, C, D, E, F, G, H, I, J Y K); SIENDO CADA R 3 , R 4 , R 5 , R 6 , R SUB,7 , R 8 Y R 9 , QUE PUEDEN SER IGUALES O DIFERENT ES, HIDROGENO O ALQUILO C 1 - C 4 , Y M ES 0, 1 O 2; O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO. TALES COMPUESTOS SON UTILES COMO AGENTES ANTINEOPLASTICOS Y ANTIVIRICOS.
ES97920753T 1996-05-14 1997-04-24 Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos. Expired - Lifetime ES2160951T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9610079.7A GB9610079D0 (en) 1996-05-14 1996-05-14 Distamycin deriratives process for preparing them and their use as antitumor and antiviral agents

Publications (1)

Publication Number Publication Date
ES2160951T3 true ES2160951T3 (es) 2001-11-16

Family

ID=10793694

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97920753T Expired - Lifetime ES2160951T3 (es) 1996-05-14 1997-04-24 Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos.

Country Status (26)

Country Link
US (1) US6177408B1 (es)
EP (1) EP0912509B1 (es)
JP (1) JP2000510129A (es)
CN (1) CN1089755C (es)
AR (1) AR007108A1 (es)
AT (1) ATE203011T1 (es)
AU (1) AU721140B2 (es)
BR (1) BR9709451A (es)
CA (1) CA2253652A1 (es)
DE (1) DE69705622T2 (es)
DK (1) DK0912509T3 (es)
EA (1) EA002273B1 (es)
ES (1) ES2160951T3 (es)
GB (1) GB9610079D0 (es)
GR (1) GR3036824T3 (es)
HU (1) HUP9901387A3 (es)
IL (1) IL126840A (es)
MY (1) MY118004A (es)
NO (1) NO311886B1 (es)
NZ (1) NZ332923A (es)
PL (1) PL329878A1 (es)
PT (1) PT912509E (es)
TW (1) TW498066B (es)
UA (1) UA45457C2 (es)
WO (1) WO1997043258A1 (es)
ZA (1) ZA973883B (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9806692D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
GB9806689D0 (en) * 1998-03-27 1998-05-27 Pharmacia & Upjohn Spa Acryloyl derivatives analogous to distamycin,process for preparing them,and their use as antitumour and antiviral agents
GB9812211D0 (en) * 1998-06-05 1998-08-05 Pharmacia & Upjohn Spa Cinnamoyl distamycin analogous derivatives,process for their preparation,and their use as antitumor agents
GB9816652D0 (en) * 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9816653D0 (en) * 1998-07-30 1998-09-30 Pharmacia & Upjohn Spa Oxidised sulfurated distamycin derivatives process for preparing them and their use as antitumor agents
GB9928703D0 (en) * 1999-12-03 2000-02-02 Pharmacia & Upjohn Spa Acryloyl peptidic derivatives,process for their preparation and their use as antitumour agents
US6559125B1 (en) 2000-01-28 2003-05-06 California Institute Of Technology Polyamide-alkylator conjugates and related products and method
GB0011059D0 (en) 2000-05-08 2000-06-28 Pharmacia & Upjohn Spa Use of substituted acryloyl distamycin derivatives in the treatment of tumours associated with high levels of glutathione
GB0015447D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl derivates and alkylating agents
GB0015446D0 (en) 2000-06-23 2000-08-16 Pharmacia & Upjohn Spa Combined therapy against tumors comprising substituted acryloyl distamycin derivates,taxanes and/or antimetabolites
GB0016447D0 (en) * 2000-07-04 2000-08-23 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0017852D0 (en) * 2000-07-20 2000-09-06 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
GB0029004D0 (en) 2000-11-28 2001-01-10 Pharmacia & Upjohn Spa Process for preparing distamycin derivatives
WO2002101007A2 (en) * 2001-06-13 2002-12-19 Genesoft Pharmaceuticals, Inc Antipathogenic benzamide compounds
EP1470119A4 (en) * 2001-06-13 2005-10-19 Genesoft Pharmaceuticals Inc BENZOTHIOPHENE COMPOUNDS WITH ANTI-INFECTIOUS ACTIVITY
US6969592B2 (en) 2001-09-26 2005-11-29 Pharmacia Italia S.P.A. Method for predicting the sensitivity to chemotherapy
KR102573190B1 (ko) 2015-10-16 2023-09-01 삼성전자주식회사 전자장치 및 전자장치 제조방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8612218D0 (en) * 1986-05-20 1986-06-25 Erba Farmitalia Site specific alkylating agents
GB9416005D0 (en) * 1994-08-08 1994-09-28 Erba Carlo Spa Peptidic compounds analogous to distamycin a and process for their preparation

Also Published As

Publication number Publication date
AU721140B2 (en) 2000-06-22
UA45457C2 (uk) 2002-04-15
EP0912509A1 (en) 1999-05-06
EP0912509B1 (en) 2001-07-11
TW498066B (en) 2002-08-11
NO311886B1 (no) 2002-02-11
EA002273B1 (ru) 2002-02-28
PL329878A1 (en) 1999-04-12
NO985307L (no) 1999-01-12
GB9610079D0 (en) 1996-07-17
DE69705622D1 (de) 2001-08-16
AU2701697A (en) 1997-12-05
ATE203011T1 (de) 2001-07-15
IL126840A (en) 2002-03-10
CA2253652A1 (en) 1997-11-20
NZ332923A (en) 2000-03-27
HK1020734A1 (en) 2000-05-19
HUP9901387A3 (en) 2002-10-28
DK0912509T3 (da) 2001-10-22
JP2000510129A (ja) 2000-08-08
CN1222144A (zh) 1999-07-07
ZA973883B (en) 1997-12-08
AR007108A1 (es) 1999-10-13
EA199801013A1 (ru) 1999-06-24
DE69705622T2 (de) 2002-05-08
IL126840A0 (en) 1999-09-22
GR3036824T3 (en) 2002-01-31
HUP9901387A2 (hu) 2000-04-28
MY118004A (en) 2004-08-30
PT912509E (pt) 2001-12-28
US6177408B1 (en) 2001-01-23
NO985307D0 (no) 1998-11-13
CN1089755C (zh) 2002-08-28
WO1997043258A1 (en) 1997-11-20
BR9709451A (pt) 1999-08-10

Similar Documents

Publication Publication Date Title
ES2160951T3 (es) Derivados de distamicina, procedimiento para la preparacion de los mismos y su uso como agentes antitumorales y antiviricos.
CO4700455A1 (es) Derivados tetraciclicos y proceso para su preparacion
ES2113368T3 (es) Antagonistas de serotonina.
ES2188584T3 (es) Derivados heterociclicos de amina.
ES2175615T3 (es) Derivados de azaindol etilamina como agentes de union al receptor nicotinico de acetilcolina.
DE69932173D1 (de) Adenine-derivate
ES2072627T3 (es) Derivados de piridina y n-oxido de piridina de diarilmetilpiperidinas o piperazinas, composiciones y uso de las mismas.
SV1999000141A (es) Derivados de quinolin-2-ona alquinilsustituidos utiles como agentes anticancerosos ref. pc10411abcz/bb
ES2149215T3 (es) Bencilaminoquinuclidinas sustituidas como antagonistas de la sustancia p.
AR002012A1 (es) Un compuesto, una composicion farmaceutica que lo comprende, su uso, metodo de tratamiento terapeutico, metodo para la preparacion del compuesto.
ES2143238T3 (es) Derivados de 1-(piperidinil disustituido en posiciones 1,2)-piperazinas sustituidas en posicion 4.
ES2122043T3 (es) Nuevos derivados sustituidos del pirazol, procedimientos para su preparacion y su empleo como herbicidas.
NO180538C (no) N-sulfonyl-2-oksoindol-derivater som har affinitet for vasopressin- og/eller ocytocin-reseptorer, farmasöytiske blandinger som inneholder dem og mellomprodukter ved fremstilling av derivatene
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
UY27322A1 (es) Nuevos derivados de indol con afinidad por el receptor 5-ht6
ES2063256T3 (es) Derivados avermectin cetales utiles como agentes antiparasitarios.
MX9202166A (es) Derivados de amidino fenil alanina, procedimiento para su preparacion su empleo y agentes que los con tienen en calidad de anticoagulantes.
AR029942A1 (es) Compuestos derivados de 1,3-dihidro-2h-indol-2-ona, su utilizacion, procedimiento para su preparacion y composiciones farmaceuticas que los comprenden, medicamentos constituidos por dichos compuestos y compuestos intermediarios
ES529811A0 (es) Procedimiento para preparar derivados de n-fenil-benzamida
ES2106616T3 (es) Derivados de 11,21-bisfenilo-19-nor-pregnanos.
AR005672A1 (es) Derivados de la distamicina, proceso para prepararlos, y su utilizacion como agentes antitumorales y antivirales.
UY26920A1 (es) 7 - oxo piridopirimidinas
DK0556329T3 (da) Substituerede piperaziner som midler til behandling af centralnervesystemet
MX9306311A (es) Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
TW360652B (en) Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 912509

Country of ref document: ES